Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Schizophrenia

Recent news which mentions Schizophrenia

AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
Tickers ABBV BMY NEWS
Tags BMY why it's moving Market News
From Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
Tickers BMY NEWS RVPH
Tags Health Care Top Stories News
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Tickers BMY EIX LUCY O
Tags Exclusives O EIX
From Benzinga
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
Tickers PMBHF
Tags Guidance News Penny Stocks
From Benzinga
Psychedelics And Schizophrenia: What's The Link?
Tags General Market News Cannabis
From Benzinga
Tips on Managing Your Schizophrenia
Tickers ALKS
Tags Schizophrenia NASDAQ:ALKS NAMI
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Marketing & Marijuana: Why Responsibility Is So Important As Psychosis & Schizophrenia Among Youth Rise
Tickers CBD CURLF
Tags General Government Leafreport
From Benzinga
Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders
Tickers ADXN
Tags News Health Care Penny Stocks
From Benzinga
Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial
Tickers KRTX
Tags Market News Health Care Trading Ideas
From Benzinga
Cannabis Increases Odds Of This Disorder In Teens Despite Infrequent Use
Tags mental health Schizophrenia Cannabis
From Benzinga
Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia
Tickers ALKS
Tags General Movers Biotech
From Benzinga
Alkermes Highlights Signs and Symptoms of Schizophrenia
Tags Health & Healthcare Alkermes mental health
From 3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Gives Green Signal To Reviva Pharma's Late-Stage Schizophrenia Trial
Tickers RVPH
Tags FDA General Biotech
From Benzinga
FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders
Tickers BTAI
Tags News Health Care Trading Ideas
From Benzinga
Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets
Tickers NBIX
Tags Contracts Market News News
From Benzinga
ATAI Life's Schizophrenia Candidate Shows Promising Action In Mid-Stage Study
Tickers ATAI
Tags Health Care Trading Ideas ATAI
From Benzinga
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
Tickers TEVA
Tags TEVA Market News Health Care
From Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
Tickers NERV
Tags Benzinga Phase 3 Trial Movers
From Benzinga
Alkermes Announces Launch of 4th Annual Alkermes Pathways Research Awards® Program
Tickers ALKS
Tags Philanthropy & Cause Initiatives alcohol use disorder (AUD) Alkermes
From 3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Approves First And Only Twice-Yearly Schizophrenia Drug
Tickers JNJ
Tags Biotech Benzinga Health Care
From Benzinga
Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review
Tickers TEVA
Tags General FDA TEVA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.